A new light-based device for wound healing is showing excellent early results in the treatment of mucositis in pediatric cancer patients.1 The therapy, referred to as photobiomodulation, uses low-level lasers in the near-infrared range to stimulate and promote wound healing and regeneration. The device is being studied in the prevention and treatment of mucositis in pediatric cancer patients at West Virginia University (WVU) School of Medicine in Morgantown and other centers in the United States.
Mucositis is characterized by painful and debilitating sores in the mouth, tongue, oropharynx, and throat. It is caused by certain treatments common to cancer regimens, particularly chemotherapeutic agents that preferentially affect fast-dividing cells. Along with the direct effects on the oral cavity, therapy-associated immunosuppression can result in dramatically reduced wound healing. The mucositis generally wont resolve until the immune system recovers, which depending on the type of chemotherapy used, can result in 7 to 14 days of sores and oral pain, said Patrick Tomboc, DO, chief of the Division of Pediatric Hematology-Oncology at WVU, who is using the new light-based device on his pediatric oncology patients.
The pain caused by mucositis can sometimes be so extreme that children require intravenous pain medication and feeding tubes. Aversions to food and oral medication can develop in very young children as a consequence of enduring mucositis-associated pain. Affected children are also at risk for infection via oral sores. Some of the worst mucositis I have seen has been in the setting of bone marrow transplantation. The throat can be so inflamed that the child vomits throat tissue. Mucositis also can lead to serious infections, as the mucosal barriers are often our best way to protect against infection, said Dr Tomboc.
The photobiomodulation device is thought to improve tissue repair by reducing inflammation via reduced oxidative stress in mitochondria.2 The treatment involves inserting a probe-like device into the mouth for 1 to 2 minutes per treatment. It also can be applied on the outside of the skin in very young patients whose oral cavity is too small for the device.
Currently, the device is used prophylactically 3 times a week in patients who are at risk for mucositis or daily as a treatment in those in whom mucositis has developed. Because limitations such as device size exist in the use of photobiomodulation in the pediatric setting, Dr Tomboc and his team are developing a smaller device. It seems to be a painless intervention, and I dont know of any side effects, he explained. The team is planning a prospective study to evaluate photobiomodulation in pediatric cancer patients with mucositis.
In relating observations regarding device efficacy, Dr Tomboc noted that hospitalization time can be greatly reduced. One patient admitted for mucositis was in for 13 days and on patient-controlled analgesia for 10 days. When the same patient was admitted a second time, he was treated with photobiomodulation. Hospital stay was reduced to 4 days, and his mucositis resolved long before his white blood cell counts recovered, said Dr Tomboc. Clinically, the results have been very surprising. Although the number of patients that we have treated so far has been small, we have seen very effective results. We have achieved resolution of mucositis without immune system suppression, he added.
Low-level laser therapy is indicated by a multinational supportive care association for treatment of oral mucositis in adults, explained Geraldine Jacobson, MD, chair of the Department of Radiation Oncology at WVU. We have been using this treatment in the Department of Radiation Oncology since June to reduce oral mucositis in our head and neck cancer patients.
Studies on the benefit in children so far have been inconclusive.3 A clinical trial that is looking at photobiomodulation in pediatric patients who have received hematopoietic stem cell transplants is currently underway (NCT04227340).
Weve seen some amazing responses, said Belinda N. Mandrell, PhD, RN, principal investigator of the clinical trial and director of Division of Nursing Research at St. Jude Childrens Research Hospital in Memphis, Tennessee. We have a few patients who did not get the light therapy with first transplant but did with subsequent transplants. One patient had grade 3 mucositis before light therapy. Following light therapy with second transplant, no mucositis developed at all. The patients and their families are very impressed with the difference that light therapy has made, said Dr Mandrell.
The clinical trial has recruited approximately 60 patients, most of whom have acute lymphoblastic or acute myelogenous leukemia and are undergoing hematopoietic stem cell transplantation. In this trial, the light therapy is being used preventatively, with the results being compared with historical controls. We start the therapy on the first day of conditioning and continue until Day 20 or engraftment is confirmed for 2 consecutive days. Weve treated children as young as 4 months without difficulty, she explained.
Dr Mandrell and colleagues will be doing an interim analysis shortly, with a look at metrics of success, such as days of hospitalization, use of pain medication, and emergence of infections. Although results of the trial are pending, she has been impressed with the therapy so far and hopes that it will become more widely used. After I look at the study data, I want to get the evidence into clinical practice to help prevent oral mucositis. I will then look outside of the hematopoietic stem cell transplant population to other patients, such as those getting high-dose chemotherapy, said Dr Mandrell.
References
Continue reading here:
Light-Based Therapy Shows Promise in Treating Mucositis in Pediatric Cancer Patients - Cancer Therapy Advisor
- Illumina's Nonprofit Partner Future Kings Is Cultivating the Next Generation of STEM Leaders - Yahoo Finance - January 20th, 2022
- Get the 2021 Garden Calendar - West Virginia University - July 21st, 2021
- Stem Cell Morgantown West Virginia 26508 - September 14th, 2019
- Wei Du | Health Sciences Directory | West Virginia University - September 14th, 2019
- Stem Cell Charleston West Virginia 25314 - February 24th, 2019
- Stem Cell Charleston West Virginia 25350 - November 21st, 2018
- Stem Cell Martinsburg West Virginia 25403 - July 25th, 2018
- FDA Cracks Down On Stem-Cell Clinics Selling Unapproved Treatments - West Virginia Public Broadcasting - September 2nd, 2017
- Kayhi grad represents Alaska at national camp - Ketchikan Daily News - September 2nd, 2017
- Hispanics left out of clinical trials and cutting-edge treatments - Wisconsin Gazette - August 12th, 2017
- Woodrow Wilson baseball field to be renamed for Tom Parham - Beckley Register-Herald - August 12th, 2017
- Latinos left out of clinical trials and possible cures - Daily Democrat - July 30th, 2017
- West Virginia University Hospitals | BMT InfoNet - November 23rd, 2016
- Regenerative Medicine In Pain Management - Boost Medical - October 20th, 2016
- SAGE Reference - West Virginia - August 7th, 2016
- Statement on Stem Cells and Cell Therapies for Lung Diseases - November 4th, 2015
- Front Matter | Guidelines for Human Embryonic Stem Cell ... - November 4th, 2015
- Stem Cell Recount: A Hair Loss Cure On the Way? - October 4th, 2015
- Train Derailment in West Virginia Causes House Fire - TIME.com - September 14th, 2015
- WV MetroNews - September 4th, 2015
- STEM All-Female High School Camp - West Virginia University - August 18th, 2015
- index | WVU Statler College - August 18th, 2015
- Home | Political Science | West Virginia University - August 12th, 2015
- Major Study Update: Stem Cells Ease Back Pain ... - August 5th, 2015
- Doctors in West Virginia who treat or diagnose Stem Cell ... - August 1st, 2015
- Mouse Mesenchymal Stem Cell Marker Antibody Panel - July 13th, 2015
- The Irvine Stem Cell Treatment Center Announces the ... - July 2nd, 2015
- Martinsburg WV Stem Cell Therapy - Cord Blood Search Tools - June 9th, 2015
- The Dallas PRP and Stem Cell Institute Announces New ... - June 4th, 2015
- Stem Cell Research, Morality, and Law - May 4th, 2015
- Targeted viral therapy destroys breast cancer stem cells ... - March 27th, 2015
- The miraculous healing powers of oxygen - February 2nd, 2015
- Paul Allen gives 100 million to explore how cells work - December 9th, 2014
- Microsoft Co-Founder Establishes Cell Institute with $100 Million Grant - December 9th, 2014
- West Point Stem Cell Therapy, Stem Cell Therapy West Point ... - September 25th, 2014
- West McLean Stem Cell Therapy, Stem Cell Therapy West ... - September 25th, 2014
- Tse Named Director of Bone Marrow Transplantation Division at University of Louisville - September 24th, 2014
- West Virginia (Stem Cell) - what-when-how - August 21st, 2014
- Stem cell treatment for copd - August 21st, 2014